Marburgvirus Infection Market, Global Outlook and Forecast 2022-2028

Marburgvirus Infection Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281533 | No. of Pages: 61 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Marburgvirus Infection in Global, including the following market information:
Global Marburgvirus Infection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Marburgvirus Infection market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Eritoran Tetrasodium Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Marburgvirus Infection include Arno Therapeutics Inc, BioCryst Pharmaceuticals Inc, Eisai Co Ltd, Emergent BioSolutions Inc, Fab'entech SA, Integrated BioTherapeutics Inc, Johnson & Johnson, NanoViricides Inc and Profectus BioSciences Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Marburgvirus Infection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Marburgvirus Infection Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Marburgvirus Infection Market Segment Percentages, by Type, 2021 (%)
    Eritoran Tetrasodium
    AR-12
    ARD-5
    AVI-7288
    Others
Global Marburgvirus Infection Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Marburgvirus Infection Market Segment Percentages, by Application, 2021 (%)
    Hospital
    Clinic
    Others
Global Marburgvirus Infection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Marburgvirus Infection Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Marburgvirus Infection revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Marburgvirus Infection revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Arno Therapeutics Inc
    BioCryst Pharmaceuticals Inc
    Eisai Co Ltd
    Emergent BioSolutions Inc
    Fab'entech SA
    Integrated BioTherapeutics Inc
    Johnson & Johnson
    NanoViricides Inc
    Profectus BioSciences Inc
    Rodos BioTarget GmbH
    Sarepta Therapeutics Inc
    Theravectys SA
1 Introduction to Research & Analysis Reports
    1.1 Marburgvirus Infection Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Marburgvirus Infection Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Marburgvirus Infection Overall Market Size
    2.1 Global Marburgvirus Infection Market Size: 2021 VS 2028
    2.2 Global Marburgvirus Infection Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Marburgvirus Infection Players in Global Market
    3.2 Top Global Marburgvirus Infection Companies Ranked by Revenue
    3.3 Global Marburgvirus Infection Revenue by Companies
    3.4 Top 3 and Top 5 Marburgvirus Infection Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Marburgvirus Infection Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Marburgvirus Infection Players in Global Market
        3.6.1 List of Global Tier 1 Marburgvirus Infection Companies
        3.6.2 List of Global Tier 2 and Tier 3 Marburgvirus Infection Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Marburgvirus Infection Market Size Markets, 2021 & 2028
        4.1.2 Eritoran Tetrasodium
        4.1.3 AR-12
        4.1.4 ARD-5
        4.1.5 AVI-7288
        4.1.6 Others
    4.2 By Type - Global Marburgvirus Infection Revenue & Forecasts
        4.2.1 By Type - Global Marburgvirus Infection Revenue, 2017-2022
        4.2.2 By Type - Global Marburgvirus Infection Revenue, 2023-2028
        4.2.3 By Type - Global Marburgvirus Infection Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Marburgvirus Infection Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Marburgvirus Infection Revenue & Forecasts
        5.2.1 By Application - Global Marburgvirus Infection Revenue, 2017-2022
        5.2.2 By Application - Global Marburgvirus Infection Revenue, 2023-2028
        5.2.3 By Application - Global Marburgvirus Infection Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Marburgvirus Infection Market Size, 2021 & 2028
    6.2 By Region - Global Marburgvirus Infection Revenue & Forecasts
        6.2.1 By Region - Global Marburgvirus Infection Revenue, 2017-2022
        6.2.2 By Region - Global Marburgvirus Infection Revenue, 2023-2028
        6.2.3 By Region - Global Marburgvirus Infection Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Marburgvirus Infection Revenue, 2017-2028
        6.3.2 US Marburgvirus Infection Market Size, 2017-2028
        6.3.3 Canada Marburgvirus Infection Market Size, 2017-2028
        6.3.4 Mexico Marburgvirus Infection Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Marburgvirus Infection Revenue, 2017-2028
        6.4.2 Germany Marburgvirus Infection Market Size, 2017-2028
        6.4.3 France Marburgvirus Infection Market Size, 2017-2028
        6.4.4 U.K. Marburgvirus Infection Market Size, 2017-2028
        6.4.5 Italy Marburgvirus Infection Market Size, 2017-2028
        6.4.6 Russia Marburgvirus Infection Market Size, 2017-2028
        6.4.7 Nordic Countries Marburgvirus Infection Market Size, 2017-2028
        6.4.8 Benelux Marburgvirus Infection Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Marburgvirus Infection Revenue, 2017-2028
        6.5.2 China Marburgvirus Infection Market Size, 2017-2028
        6.5.3 Japan Marburgvirus Infection Market Size, 2017-2028
        6.5.4 South Korea Marburgvirus Infection Market Size, 2017-2028
        6.5.5 Southeast Asia Marburgvirus Infection Market Size, 2017-2028
        6.5.6 India Marburgvirus Infection Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Marburgvirus Infection Revenue, 2017-2028
        6.6.2 Brazil Marburgvirus Infection Market Size, 2017-2028
        6.6.3 Argentina Marburgvirus Infection Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Marburgvirus Infection Revenue, 2017-2028
        6.7.2 Turkey Marburgvirus Infection Market Size, 2017-2028
        6.7.3 Israel Marburgvirus Infection Market Size, 2017-2028
        6.7.4 Saudi Arabia Marburgvirus Infection Market Size, 2017-2028
        6.7.5 UAE Marburgvirus Infection Market Size, 2017-2028
7 Players Profiles
    7.1 Arno Therapeutics Inc
        7.1.1 Arno Therapeutics Inc Corporate Summary
        7.1.2 Arno Therapeutics Inc Business Overview
        7.1.3 Arno Therapeutics Inc Marburgvirus Infection Major Product Offerings
        7.1.4 Arno Therapeutics Inc Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.1.5 Arno Therapeutics Inc Key News
    7.2 BioCryst Pharmaceuticals Inc
        7.2.1 BioCryst Pharmaceuticals Inc Corporate Summary
        7.2.2 BioCryst Pharmaceuticals Inc Business Overview
        7.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Major Product Offerings
        7.2.4 BioCryst Pharmaceuticals Inc Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.2.5 BioCryst Pharmaceuticals Inc Key News
    7.3 Eisai Co Ltd
        7.3.1 Eisai Co Ltd Corporate Summary
        7.3.2 Eisai Co Ltd Business Overview
        7.3.3 Eisai Co Ltd Marburgvirus Infection Major Product Offerings
        7.3.4 Eisai Co Ltd Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.3.5 Eisai Co Ltd Key News
    7.4 Emergent BioSolutions Inc
        7.4.1 Emergent BioSolutions Inc Corporate Summary
        7.4.2 Emergent BioSolutions Inc Business Overview
        7.4.3 Emergent BioSolutions Inc Marburgvirus Infection Major Product Offerings
        7.4.4 Emergent BioSolutions Inc Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.4.5 Emergent BioSolutions Inc Key News
    7.5 Fab'entech SA
        7.5.1 Fab'entech SA Corporate Summary
        7.5.2 Fab'entech SA Business Overview
        7.5.3 Fab'entech SA Marburgvirus Infection Major Product Offerings
        7.5.4 Fab'entech SA Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.5.5 Fab'entech SA Key News
    7.6 Integrated BioTherapeutics Inc
        7.6.1 Integrated BioTherapeutics Inc Corporate Summary
        7.6.2 Integrated BioTherapeutics Inc Business Overview
        7.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Major Product Offerings
        7.6.4 Integrated BioTherapeutics Inc Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.6.5 Integrated BioTherapeutics Inc Key News
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Corporate Summary
        7.7.2 Johnson & Johnson Business Overview
        7.7.3 Johnson & Johnson Marburgvirus Infection Major Product Offerings
        7.7.4 Johnson & Johnson Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.7.5 Johnson & Johnson Key News
    7.8 NanoViricides Inc
        7.8.1 NanoViricides Inc Corporate Summary
        7.8.2 NanoViricides Inc Business Overview
        7.8.3 NanoViricides Inc Marburgvirus Infection Major Product Offerings
        7.8.4 NanoViricides Inc Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.8.5 NanoViricides Inc Key News
    7.9 Profectus BioSciences Inc
        7.9.1 Profectus BioSciences Inc Corporate Summary
        7.9.2 Profectus BioSciences Inc Business Overview
        7.9.3 Profectus BioSciences Inc Marburgvirus Infection Major Product Offerings
        7.9.4 Profectus BioSciences Inc Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.9.5 Profectus BioSciences Inc Key News
    7.10 Rodos BioTarget GmbH
        7.10.1 Rodos BioTarget GmbH Corporate Summary
        7.10.2 Rodos BioTarget GmbH Business Overview
        7.10.3 Rodos BioTarget GmbH Marburgvirus Infection Major Product Offerings
        7.10.4 Rodos BioTarget GmbH Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.10.5 Rodos BioTarget GmbH Key News
    7.11 Sarepta Therapeutics Inc
        7.11.1 Sarepta Therapeutics Inc Corporate Summary
        7.11.2 Sarepta Therapeutics Inc Business Overview
        7.11.3 Sarepta Therapeutics Inc Marburgvirus Infection Major Product Offerings
        7.11.4 Sarepta Therapeutics Inc Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.11.5 Sarepta Therapeutics Inc Key News
    7.12 Theravectys SA
        7.12.1 Theravectys SA Corporate Summary
        7.12.2 Theravectys SA Business Overview
        7.12.3 Theravectys SA Marburgvirus Infection Major Product Offerings
        7.12.4 Theravectys SA Marburgvirus Infection Revenue in Global Market (2017-2022)
        7.12.5 Theravectys SA Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com